• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing
  3. / Healthcare

MedMen sees traction in California despite market challenges

Matt Karnes, the founder of cannabis industry analytics firm GreenWave Advisors, said that based on his estimates of public sales and dispensary data, MedMen is outpacing the statewide average between $200,000 and $250,000 quarterly revenue per store.
By STEVE GELSI Aug 17, 2018 | 03:15 PM EDT
Stocks quotes in this article: MMNFF

MedMen Enterprises Inc.  (MMNFF)  said that early sales in California met expectations, as the Los Angeles cannabis producer and retailer signals some success in what's been a sluggish roll-out in the state's colossal adult use cannabis business.

Although it's the currently largest adult use cannabis market in the world -- outstripping Canada's entire national demand -- local licensing efforts and competition from illegal sales stalled California's industry, market players say.

MedMen on Thursday said its systemwide revenue for the fourth quarter ending June 30 totaled $19.2 million, describing it as "strong" and offering a glimpse of its store economics in the Southern California market. 

The company said excluding its Abbot Kinney store in Southern California, which opened in early June, its other seven LA region retail booked $17.4 million quarterly revenue and an average $77.76 spend per transaction. Its average retail market markup over wholesale was 90%. About 130,000 customers returned from the previous quarter, and it gained 94,000 new customers. The company will provide full, audited fourth-quarter results in October.

MedMen spokesman Daniel Yi told Real Money the results matched company expectations. While some local jurisdictions have stalled, LA's local license issuance, where MedMen mostly operates, has been worked out for much of the year, he said.

Matt Karnes, the founder of cannabis industry analytics firm GreenWave Advisors, said that based on his estimates of public sales and dispensary data, MedMen is outpacing the statewide average between $200,000 and $250,000 quarterly revenue per store.

But MedMen and other companies continue to face competition from lower black market prices. The state's also collected less tax revenue than expected.

The California Department of Tax and Fee Administration (CDTFA) on Wednesday said second-quarter cannabis industry tax revenue totaled $74 million, up from $60.9 million in the first quarter. The combined $134.9 million six-month take missed Gov. Jerry Brown's office's $175 million projection.

Karnes said California's legal cannabis -- and its tax revenue -- would gain traction over time as illegal sales slowly phase out in the state.

"It's going to take time for the illicit market to transition into the legal market," Karnes said. "Law enforcement will take measures so that the illicit market continues to face disruption. Illegal sales are a hiccup, but it'll eventually be rationalized, and we'll see the full potential of the California market."

All told, the legal marijuana business has been expected to be one of California's fastest growing industries for the next five years, according to market data. The market is expected to reach $10 billion by about 2025, according to market sources cited in MedMen's public filings.

A study released Aug 8 by cannabis delivery service Eaze said 84% of Californians are very satisfied with the legal market thus far, but that one in five state residents has purchased cannabis from the illicit market in the past three months. The survey also concluded that a 5% decrease in the overall tax rate in California could drive 23% of illicit market supporters into the legal market.

To entice more buyers from unregistered stores, the state Legislature has been considering a measure to reduce the cannabis excise tax to 11% from 15%, but so far nothing has been decided.

For its part in California and elsewhere, MedMen plans to grow its own cannabis supply and integrate production with its retailing arm. It recently opened a 45,000-square-foot cultivation and manufacturing facility in northern Nevada. It's using the same design for a Desert Hot Springs, California facility expected online by early 2019. The company plans to build similar factories in New York, and possibly Florida.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.
TAGS: Investing | U.S. Equity | Regulation | Markets | Healthcare | Consumer Staples | Consumer Discretionary | Earnings | Consumer | Executive Interview | Gaming | E-Commerce | Stocks

More from Healthcare

Checking In on Pacific Biosciences to See If It's Still a Good 'Idea'

Bruce Kamich
Mar 31, 2023 9:02 AM EDT

Let's review the charts of PACB again.

Does Silk Road Medical Have a Smooth Path Forward?

Bruce Kamich
Mar 31, 2023 8:11 AM EDT

After gaining a fundamental supporter, here's how aggressive traders could play the stock.

Medtronic Could Touch a New Low as It Bottoms

Bruce Kamich
Mar 29, 2023 9:30 AM EDT

Let's see what the the charts and indicators look like.

Gilead Sciences Could Retreat Further From Here

Bruce Kamich
Mar 27, 2023 9:25 AM EDT

Share prices peaked in December.

Boston Scientific's Wicked Rally Can Take the Stock 20% Higher

Bruce Kamich
Mar 21, 2023 2:59 PM EDT

BSX has rallied the past nine months.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 08:21 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    How a Trader Becomes a Money Manager
  • 04:00 PM EDT CHRIS VERSACE

    AAP Podcast: This Solar Company Is a Head-Turner

    Listen to my interview with Brian Roth, CEO of sol...
  • 01:56 PM EDT PETER TCHIR

    Very Cautious

    I am very cautious here. I don't like how the c...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login